Other
Pain Control
0
Pipeline Programs↗
17
Active Trials↗
2
Companies Involved↗
Pain Control is an early-stage landscape with 0 programs across 2 companies. The most active players are Cumberland Pharmaceuticals, Xgene Pharmaceutical Group.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
82
clinical trials
Completed49 · 60%
Recruiting10 · 12%
Unknown status9 · 11%
Not yet recruiting5 · 6%
Terminated4 · 5%
Withdrawn3 · 4%
Other2 · 2%
Clinical Trials
Trial Activity
82 trials
Page 1 of 6
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)